Literature DB >> 10662831

A role for nuclear PTEN in neuronal differentiation.

M B Lachyankar1, N Sultana, C M Schonhoff, P Mitra, W Poluha, S Lambert, P J Quesenberry, N S Litofsky, L D Recht, R Nabi, S J Miller, S Ohta, B G Neel, A H Ross.   

Abstract

Mutations of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a protein and lipid phosphatase, have been associated with gliomas, macrocephaly, and mental deficiencies. We have assessed PTEN's role in the nervous system and find that PTEN is expressed in mouse brain late in development, starting at approximately postnatal day 0. In adult brain, PTEN is preferentially expressed in neurons and is especially evident in Purkinje neurons, olfactory mitral neurons, and large pyramidal neurons. To analyze the function of PTEN in neuronal differentiation, we used two well established model systems-pheochromocytoma cells and cultured CNS stem cells. PTEN is expressed during neurotrophin-induced differentiation and is detected in both the nucleus and cytoplasm. Suppression of PTEN levels with antisense oligonucleotides does not block initiation of neuronal differentiation. Instead, PTEN antisense leads to death of the resulting, immature neurons, probably during neurite extension. In contrast, PTEN is not required for astrocytic differentiation. These observations indicate that PTEN acts at multiple sites in the cell, regulating the transition of differentiating neuroblasts to postmitotic neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10662831      PMCID: PMC6772384     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  58 in total

1.  PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.

Authors:  D M Li; H Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 2.  Phosphorothioate antisense oligodeoxynucleotides: questions of specificity.

Authors:  C A Stein
Journal:  Trends Biotechnol       Date:  1996-05       Impact factor: 19.536

3.  Multiple isoforms of the regulatory subunit for phosphatidylinositol 3-kinase (PI3-kinase) are expressed in neurons in the rat brain.

Authors:  B C Shin; M Suzuki; K Inukai; M Anai; T Asano; K Takata
Journal:  Biochem Biophys Res Commun       Date:  1998-05-19       Impact factor: 3.575

4.  TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.

Authors:  D M Li; H Sun
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

5.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

6.  A role for nuclear phosphatidylinositol-specific phospholipase C in the G2/M phase transition.

Authors:  B Sun; N R Murray; A P Fields
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

7.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

8.  Cytoplasmic and nuclear localization sites of phosphatidylinositol 3-kinase in human osteosarcoma sensitive and multidrug-resistant Saos-2 cells.

Authors:  N Zini; A Ognibene; A Bavelloni; S Santi; P Sabatelli; N Baldini; K Scotlandi; M Serra; N M Maraldi
Journal:  Histochem Cell Biol       Date:  1996-11       Impact factor: 4.304

9.  The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.

Authors:  F B Furnari; H J Huang; W K Cavenee
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

10.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

View more
  72 in total

1.  Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells.

Authors:  A Perren; P Komminoth; P Saremaslani; C Matter; S Feurer; J A Lees; P U Heitz; C Eng
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Active zone density is conserved during synaptic growth but impaired in aged mice.

Authors:  Jie Chen; Takafumi Mizushige; Hiroshi Nishimune
Journal:  J Comp Neurol       Date:  2012-02-01       Impact factor: 3.215

3.  A PTEN-Regulated Checkpoint Controls Surface Delivery of δ Opioid Receptors.

Authors:  Daniel J Shiwarski; Alycia Tipton; Melissa D Giraldo; Brigitte F Schmidt; Michael S Gold; Amynah A Pradhan; Manojkumar A Puthenveedu
Journal:  J Neurosci       Date:  2017-03-06       Impact factor: 6.167

4.  Inhibition of neuronal phenotype by PTEN in PC12 cells.

Authors:  Sergei Musatov; Jill Roberts; Andrew I Brooks; John Pena; Simone Betchen; Donald W Pfaff; Michael G Kaplitt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

5.  Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs.

Authors:  Anabel Gil; Amparo Andrés-Pons; Elena Fernández; Miguel Valiente; Josema Torres; Javier Cervera; Rafael Pulido
Journal:  Mol Biol Cell       Date:  2006-06-28       Impact factor: 4.138

6.  Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.

Authors:  N R Leslie; D Bennett; A Gray; I Pass; K Hoang-Xuan; C P Downes
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

7.  Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death.

Authors:  Brendan Lujan; Xiaoxuan Liu; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

8.  Akt phosphorylation and nuclear phosphoinositide association mediate mRNA export and cell proliferation activities by ALY.

Authors:  Masashi Okada; Sang-Wuk Jang; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-17       Impact factor: 11.205

9.  Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons.

Authors:  Oscar Diaz-Ruiz; Agustin Zapata; Lufei Shan; YaJun Zhang; Andreas C Tomac; Nasir Malik; Fidel de la Cruz; Cristina M Bäckman
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

10.  NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration.

Authors:  Young-Don Kwak; Tao Ma; Shiyong Diao; Xue Zhang; Yaomin Chen; Janet Hsu; Stuart A Lipton; Eliezer Masliah; Huaxi Xu; Francesca-Fang Liao
Journal:  Mol Neurodegener       Date:  2010-11-10       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.